The Nigerian National Primary Health Care Development Agency (NPHCDA) has provided an update on people who received coronavirus vaccines.
After taking the first dose of COVID-19, 10,027 Nigerians reported mild, moderate, and severe adverse effects, according to the NPHCDA.
Following their first dose of the vaccine, many Nigerians reported mild, moderate, and adverse effects Following Immunization, or AEFI, according to Dr Faisal Shuaib, the Executive Director of the NPHCDA.
Those who were afflicted, according to Shuaib, had pains and swelling at the immunisation site, as well as headaches and gastrointestinal discomfort.
He said this at a news conference in Abuja Wednesday when he was presenting an update on the COVID-19 vaccine.
“Since we formally rolled out Covid-19 vaccine on March 15, 2021, there have been cases of mild, moderate, and severe Adverse Events Following Immunization (AEFI),” according to the NPHCDA head.
Headaches, abdominal pain, fever, disorientation, and allergic reactions were among the AEFls symptoms, which ranged from discomfort and swelling at the injection site to more significant symptoms such as headaches, abdominal pain, fever, dizziness, and allergic reactions.
ALSO READ : Lady Killed Inside Her Room In Delta With Her Vital Organs Removed Hours After Coming Home With A Strange Man
Jobs in Nigeria [Apply Now]
- WAEC 2022 Massive Recruitment – WAEC Recruitment Portal login
- Lagos State Ministry of Health Recruitment 2022 for Ond, Bsc /HND
- Job Vacancies at Christ the Redeemer Secondary Schools for Teaching and Non-teaching Staff
- Nationwide Recruitment for Graduate Service Executives in a Commercial Bank – MacTay Consulting